Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PVLA

Palvella Therapeutics Inc

May 01 • 04:00PM ET

126.84

-1.48 -1.15 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SRPT AGEN ADAP BLUE KURA FATE MRNA NVAX CRSP SGMO

| Held by: VTI XBI IWM VXF IWO VTWO VHT VFMO IWC LABU

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.71	Insider Own	27.89%	Shs Outstand	12.38M	Perf Week	2.63%
Market Cap	1.82B	Forward P/E	-	EPS next Y	-6.04	Insider Trans	-0.47%	Shs Float	10.32M	Perf Month	5.37%
Enterprise Value	1.78B	PEG	-	EPS next Q	-0.94	Inst Own	63.02%	Short Float	19.18%	Perf Quarter	65.39%
Income	-41.72M	P/S	-	EPS this Y	-39.20%	Inst Trans	21.59%	Short Ratio	6.35	Perf Half Y	68.74%
Sales	0.00M	P/B	56.12	EPS next Y	-16.97%	ROA	-	Short Interest	1.98M	Perf YTD	21.18%
Book/sh	2.26	P/C	31.31	EPS next 5Y	16.60%	ROE	-	52W High	151.18 -16.10%	Perf Year	426.53%
Cash/sh	4.05	P/FCF	-	EPS past 3/5Y	53.08% 41.62%	ROIC	-90.34%	52W Low	20.20 527.92%	Perf 3Y	113.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.18% 5.68%	Perf 5Y	-26.60%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	70.61%	Oper. Margin	-	ATR (14)	7.62	Perf 10Y	-21.12%
Dividend Ex-Date	-	Quick Ratio	5.20	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.26	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.20	EPS Q/Q	50.55%	SMA20	0.06%	Beta	-0.12	Target Price	229.44
Payout	-	Debt/Eq	0.66	Sales Q/Q	-	SMA50	1.68%	Rel Volume	0.55	Prev Close	128.32
Employees	29	LT Debt/Eq	0.65	Earnings	May 07 BMO	SMA200	47.73%	Avg Volume	311.79K	Price	126.84
IPO	Jan 02, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-18.53% -	Trades		Volume	170,530	Change	-1.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)